Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NGL Fine-Chem's Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹558 Mil. Therefore, NGL Fine-Chem's EV-to-EBIT ratio for today is 24.94.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, NGL Fine-Chem's Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹674 Mil. Therefore, NGL Fine-Chem's EV-to-EBITDA ratio for today is 20.63.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, NGL Fine-Chem's Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,386 Mil. Therefore, NGL Fine-Chem's EV-to-Revenue ratio for today is 4.11.
NGL Fine-Chem Enterprise Value Historical Data
The historical data trend for NGL Fine-Chem's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NGL Fine-Chem's Enterprise Value
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Enterprise Value distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Enterprise Value falls into.
NGL Fine-Chem Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
NGL Fine-Chem's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem (BOM:524774) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
NGL Fine-Chem's current Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹558 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
NGL Fine-Chem's current Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹674 Mil.
NGL Fine-Chem's current Enterprise Value is ₹13,906 Mil.
NGL Fine-Chem's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,386 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem Enterprise Value Related Terms
Thank you for viewing the detailed overview of NGL Fine-Chem's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524774 has been successfully added to your 